← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

SENS logoSenseonics Holdings, Inc.(SENS)Earnings, Financials & Key Ratios

SENS•NASDAQ
$5.36
$224M mkt cap·Price updated May 7, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryDiabetes care and insulin delivery
AboutSenseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.Show more
  • Revenue$35M+56.9%
  • EBITDA-$68M+7.0%
  • Net Income-$69M+12.1%
  • EPS (Diluted)-1.66+33.6%
  • Gross Margin44.71%+1785.0%
  • EBITDA Margin-193.57%+40.7%
  • Operating Margin-193.83%+41.8%
  • Net Margin-196.03%+44.0%
  • ROE-310.68%+62.0%
  • ROIC-322.64%
  • Debt/Equity0.68
  • Interest Coverage-12.96-55.8%
Technical→

SENS Key Insights

Senseonics Holdings, Inc. (SENS) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y profit CAGR of 17.0%
  • ✓Strong 5Y sales CAGR of 48.1%

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 10 (bottom 10%)
  • ✗Shares diluted 32.5% in last year
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

SENS Price & Volume

Senseonics Holdings, Inc. (SENS) stock price & volume — 10-year historical chart

Loading chart...

SENS Growth Metrics

Senseonics Holdings, Inc. (SENS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years98.04%
5 Years48.1%
3 Years29.09%
TTM78.87%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-19.14%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM5.68%

Return on Capital

10 Years-255.02%
5 Years-64.28%
3 Years-74.06%
Last Year-83.59%

SENS Recent Earnings

Senseonics Holdings, Inc. (SENS) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 1/12 qtrs (8%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
Mar 2, 2026
EPS
$0.46
Est $0.43
-7.0%
Revenue
$14M
Est $14M
+0.4%
Q4 2025
Nov 5, 2025
EPS
$0.43
Est $0.33
-30.3%
Revenue
$8M
Est $14M
-43.1%
Q3 2025
Aug 6, 2025
EPS
$0.40
Est $0.40
+0.0%
Revenue
$8M
Est $6M
+37.8%
Q2 2025
May 8, 2025
EPS
$0.02
Est $0.02
+0.0%
Revenue
$6M
Est $6M
+12.6%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMar 2, 2026
$0.46vs $0.43-7.0%
$14Mvs $14M+0.4%
Q4 2025Nov 5, 2025
$0.43vs $0.33-30.3%
$8Mvs $14M-43.1%
Q3 2025Aug 6, 2025
$0.40vs $0.40+0.0%
$8Mvs $6M+37.8%
Q2 2025May 8, 2025
$0.02vs $0.02+0.0%
$6Mvs $6M+12.6%
Based on last 12 quarters of dataView full earnings history →

SENS Peer Comparison

Senseonics Holdings, Inc. (SENS) competitors in Diabetes care and insulin delivery — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
DXCM logoDXCMDexCom, Inc.Direct Competitor23.5B60.9129.1415.6%19.31%33.83%0.51
ABT logoABTAbbott LaboratoriesDirect Competitor151.3B87.0111.394.59%31.88%27.26%0.32
PODD logoPODDInsulet CorporationDirect Competitor11.26B160.4046.0930.73%10.44%21.38%0.69
TNDM logoTNDMTandem Diabetes Care, Inc.Direct Competitor1.27B18.47-6.087.93%-9.2%-68.29%2.86
GMED logoGMEDGlobus Medical, Inc.Product Competitor11.51B85.0821.7016.65%18.92%13.04%0.03
NVCR logoNVCRNovoCure LimitedProduct Competitor1.92B16.83-13.808.28%-25.66%-50.82%0.85
INVA logoINVAInnoviva, Inc.Product Competitor1.93B22.806.9118.52%118.91%46.47%0.23
LIVN logoLIVNLivaNova PLCProduct Competitor3.88B70.93-15.9410.74%7.47%9.13%0.39

Compare SENS vs Peers

Senseonics Holdings, Inc. (SENS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs DXCM

Most directly comparable listed peer for SENS.

Scale Benchmark

vs LLY

Larger-name benchmark to compare SENS against a more recognizable public peer.

Peer Set

Compare Top 5

vs DXCM, ABT, PODD, TNDM

SENS Income Statement

Senseonics Holdings, Inc. (SENS) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue6.37M18.91M21.3M4.95M13.68M16.39M22.39M22.47M35.26M42.36M
Revenue Growth %1819.58%196.77%12.63%-76.77%176.32%19.85%36.62%0.37%56.89%78.87%
Cost of Goods Sold9.76M27.06M40.75M22.32M14.49M13.66M19.3M21.94M19.49M20.33M
COGS % of Revenue153.11%143.07%191.3%450.9%105.93%83.37%86.19%97.63%55.29%-
Gross Profit
-3.38M▲ 0%
-8.15M▼ 140.6%
-19.45M▼ 138.7%
-17.37M▲ 10.7%
-811K▲ 95.3%
2.73M▲ 436.1%
3.09M▲ 13.4%
533K▼ 82.8%
15.76M▲ 2857.4%
22.03M▲ 0%
Gross Margin %-53.11%-43.07%-91.3%-350.9%-5.93%16.63%13.81%2.37%44.71%52%
Gross Profit Growth %-932.01%-140.65%-138.74%10.71%95.33%436.13%13.39%-82.76%2857.41%-
Operating Expenses52.93M79.43M111.21M61.76M56.37M71.35M78.69M75.38M84.1M108.67M
OpEx % of Revenue830.5%419.99%522.11%1248.01%412.22%435.37%351.47%335.42%238.53%-
Selling, General & Admin22.19M47.57M72.78M41.35M29.15M31.63M29.94M34.23M52.51M74.99M
SG&A % of Revenue348.23%251.51%341.69%835.54%213.19%193.02%133.73%152.33%148.93%-
Research & Development30.73M31.86M38.43M20.41M27.22M39.72M48.75M41.14M31.59M32.9M
R&D % of Revenue482.27%168.47%180.41%412.47%199.03%242.35%217.74%183.09%89.6%-
Other Operating Expenses176K-321K0000000778K
Operating Income
-56.31M▲ 0%
-87.58M▼ 55.5%
-130.66M▼ 49.2%
-79.13M▲ 39.4%
-57.18M▲ 27.7%
-68.63M▼ 20.0%
-75.6M▼ 10.2%
-74.84M▲ 1.0%
-68.34M▲ 8.7%
-86.59M▲ 0%
Operating Margin %-883.62%-463.06%-613.41%-1598.91%-418.15%-418.74%-337.66%-333.05%-193.83%-204.42%
Operating Income Growth %-32.71%-55.52%-49.2%39.44%27.74%-20.02%-10.17%1.01%8.69%-
EBITDA-56.09M-87.31M-129.66M-77.99M-55.94M-67.64M-74.33M-73.37M-68.25M-83.92M
EBITDA Margin %-880.05%-461.63%-608.71%-1575.85%-409.09%-412.73%-331.96%-326.48%-193.57%-198.1%
EBITDA Growth %-32.66%-55.67%-48.51%39.85%28.27%-20.91%-9.88%1.29%6.98%-22.67%
D&A (Non-Cash Add-back)227.27K270K1M1.14M1.24M985K1.28M1.48M91K2.68M
EBIT-56M-85.69M-100.41M-159M-285.75M160.82M-49.28M-70.18M-64.16M-43.69M
Net Interest Income-2.96M-6.28M-13.21M-15.99M-16.48M-16.88M-5.75M-3.94M-753K-7.75M
Interest Income135K2M1.93M175K243K1.82M5.36M4.5M4.2M4.16M
Interest Expense3.1M8.28M15.14M16.17M16.72M18.7M11.11M8.44M4.95M9.98M
Other Income/Expense-2.79M-6.39M15.11M-96.04M-245.29M210.75M15.21M-3.77M-776K-1.52M
Pretax Income
-59.1M▲ 0%
-93.97M▼ 59.0%
-115.55M▼ 23.0%
-175.17M▼ 51.6%
-302.47M▼ 72.7%
142.12M▲ 147.0%
-60.39M▼ 142.5%
-78.62M▼ 30.2%
-69.11M▲ 12.1%
-88.16M▲ 0%
Pretax Margin %-927.37%-496.86%-542.46%-3539.46%-2211.88%867.16%-269.73%-349.84%-196.03%-208.13%
Income Tax0000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%
Net Income
-59.1M▲ 0%
-93.97M▼ 59.0%
-115.55M▼ 23.0%
-175.17M▼ 51.6%
-302.47M▼ 72.7%
142.12M▲ 147.0%
-60.39M▼ 142.5%
-78.62M▼ 30.2%
-69.11M▲ 12.1%
-88.16M▲ 0%
Net Margin %-927.37%-496.86%-542.46%-3539.46%-2211.88%867.16%-269.73%-349.84%-196.03%-208.13%
Net Income Growth %-34.53%-59%-22.96%-51.6%-72.68%146.99%-142.49%-30.18%12.09%-19.14%
Net Income (Continuing)-59.1M-93.97M-115.55M-175.17M-302.47M142.12M-60.39M-78.62M-69.11M-88.16M
Discontinued Operations0000000000
Minority Interest0000000000
EPS (Diluted)
-10.20▲ 0%
-12.00▼ 17.6%
-12.20▼ 1.7%
-15.40▼ 26.2%
-14.40▲ 6.5%
-2.17▲ 84.9%
-2.20▼ 1.4%
-2.50▼ 13.6%
-1.66▲ 33.6%
-1.92▲ 0%
EPS Growth %-4.08%-17.65%-1.67%-26.23%6.49%84.93%-1.38%-13.64%33.6%5.68%
EPS (Basic)-10.20-12.00-12.20-15.40-14.406.07-2.20-2.50-1.66-
Diluted Shares Outstanding5.8M7.87M9.44M11.4M21.12M30.91M28.4M31.49M41.73M45.82M
Basic Shares Outstanding5.8M7.87M9.44M11.4M21.12M23.4M28.4M31.49M41.73M45.82M
Dividend Payout Ratio----------

SENS Balance Sheet

Senseonics Holdings, Inc. (SENS) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets44.91M158.11M127.76M30.25M144.41M161.2M130.03M91.44M117.53M92.28M
Cash & Short-Term Investments36.45M136.79M95.94M18M129.91M144.01M109.46M74.6M94.03M29.61M
Cash Only16.15M136.79M95.94M18M33.46M35.79M75.71M74.6M40.55M29.61M
Short-Term Investments20.3M00096.44M108.22M33.75M053.8M0
Accounts Receivable3.39M7.1M10.49M2.99M2.42M2.79M6.6M8.08M12.43M10.65M
Days Sales Outstanding193.93136.96179.68220.2264.4962.07107.54131.22128.6885.49
Inventory2.99M10.23M16.93M5.28M6.32M7.31M8.78M4.42M6.7M8.31M
Days Inventory Outstanding111.88138.01151.6486.38159.14195.18165.9873.55125.5116.91
Other Current Assets48K142K179K200K56K12K1K333K4.37M43.71M
Total Non-Current Assets1.03M1.87M5.04M5.67M54.52M16.47M8.19M9M8.74M10.58M
Property, Plant & Equipment853K1.75M2M1.56M1.31M1.11M1.18M3.59M4.2M4.15M
Fixed Asset Turnover7.47x10.81x10.65x3.18x10.45x14.74x18.91x6.26x8.39x8.30x
Goodwill0000000000
Intangible Assets0000000481.92K800K0
Long-Term Investments000051.88M12.25M0000
Other Non-Current Assets176K117K3.04M4.12M1.32M3.11M7.01M4.93M3.74M14.97M
Total Assets
45.94M▲ 0%
159.97M▲ 248.2%
132.8M▼ 17.0%
35.92M▼ 73.0%
198.93M▲ 453.8%
177.67M▼ 10.7%
138.22M▼ 22.2%
100.44M▼ 27.3%
126.27M▲ 25.7%
102.86M▲ 0%
Asset Turnover0.14x0.12x0.16x0.14x0.07x0.09x0.16x0.22x0.28x0.33x
Asset Growth %106.3%248.19%-16.99%-72.95%453.84%-10.68%-22.21%-27.33%25.72%123.61%
Total Current Liabilities23.14M28.89M126.71M16.64M18.39M31.47M17.26M38.85M24.35M26.32M
Accounts Payable7.71M4.41M4.29M1.76M1.2M419K4.57M3.21M4.06M3.19M
Days Payables Outstanding288.4759.4538.3828.8230.3411.1986.3953.327669.33
Short-Term Debt10M10M103.79M3.2M2.93M15.58M020.14M00
Deferred Revenue (Current)5.23M628K00000000
Other Current Liabilities3.22M10.17M7.86M5.14M-904K5.51M5.34M5.79M19.79M26.32M
Current Ratio1.94x5.47x1.01x1.82x7.85x5.12x7.53x2.35x4.83x4.83x
Quick Ratio1.81x5.12x0.87x1.50x7.51x4.89x7.03x2.24x4.55x4.55x
Cash Conversion Cycle17.34215.52292.94277.78193.29246.05187.13151.45178.19133.07
Total Non-Current Liabilities15.54M59.83M14.74M163.36M366.07M148.78M85.17M78.14M40.88M42.2M
Long-Term Debt14.41M40.97M11.8M57.22M59.8M56.38M41.2M34.7M35.59M42.2M
Capital Lease Obligations69K02.28M1.48M579K2.69M6.21M5.79M5.29M16.26M
Deferred Tax Liabilities0000000000
Other Non-Current Liabilities1.05M18.86M664K104.66M305.69M89.71M37.76M37.66M00
Total Liabilities38.68M88.71M141.45M180M384.46M180.25M102.42M116.99M65.22M68.52M
Total Debt24.48M50.97M118.56M62.7M64.21M75.38M47.78M61.05M41.37M42.2M
Net Debt8.33M-85.82M22.62M44.69M30.75M39.58M-27.93M-13.54M822K12.59M
Debt / Equity3.37x0.72x----1.33x-0.68x0.68x
Debt / EBITDA----------0.50x
Net Debt / EBITDA----------0.15x
Interest Coverage-18.07x-10.35x-6.63x-9.83x-17.09x8.60x-4.44x-8.32x-12.96x-4.38x
Total Equity
7.27M▲ 0%
71.26M▲ 880.6%
-8.65M▼ 112.1%
-144.08M▼ 1565.9%
-185.53M▼ 28.8%
-2.58M▲ 98.6%
35.8M▲ 1489.6%
-16.55M▼ 146.2%
61.05M▲ 468.7%
34.34M▲ 0%
Equity Growth %249.01%880.61%-112.14%-1565.89%-28.77%98.61%1489.6%-146.25%468.75%1168.99%
Book Value per Share1.259.05-0.92-12.64-8.79-0.081.26-0.531.460.75
Total Shareholders' Equity7.27M71.26M-8.65M-144.08M-185.53M-2.58M35.8M-16.55M61.05M34.34M
Common Stock137K177K203K266K447K480K530K595K41K42K
Retained Earnings-263.82M-357.79M-473.34M-648.51M-950.99M-808.87M-869.26M-947.87M-1.02B-1.05B
Treasury Stock0000000000
Accumulated OCI-1.04M-1.31M00-212K-678K-11K069K8K
Minority Interest0000000000

SENS Cash Flow Statement

Senseonics Holdings, Inc. (SENS) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations-55.74M-90.77M-136.05M-67.42M-56.08M-66.31M-70.16M-60.47M-59.13M-59.13M
Operating CF Margin %-874.61%-479.94%-638.69%-1362.34%-410.08%-404.61%-313.37%-269.07%-167.71%-
Operating CF Growth %-46.62%-62.85%-49.88%50.44%16.83%-18.25%-5.81%13.82%2.21%-115.2%
Net Income-59.1M-93.97M-115.55M-175.17M-302.47M142.12M-60.39M-78.62M-69.11M-88.16M
Depreciation & Amortization227K270K1M1.14M1.24M985K1.28M1.48M91K2.02M
Stock-Based Compensation3.99M6.41M8.05M7.31M9.03M8.62M8.67M9.22M10.15M10.59M
Deferred Taxes98K-123K061.82M229.17M00000
Other Non-Cash Items453K3.32M-20.07M23.68M8.46M-215.56M-15.76M6.59M3.02M-1.03M
Working Capital Changes-1.41M-6.68M-9.48M13.79M-1.5M-2.47M-3.97M865K-3.28M1.5M
Change in Receivables-3.13M-3.71M-3.28M7.39M1.01M-478K-2.19M-2.7M-6.76M-11.43M
Change in Inventory-2.74M-7.44M-6.7M15.82M-1.04M-989K-1.64M696K-2.98M-4.08M
Change in Payables4.64M-3.4M-122K-2.52M-559K-785K2.3M-1.83M1.22M1.2M
Cash from Investing-13.23M19.43M-1.04M-181K-148.75M26.88M89.71M32.84M-53.42M-10.1M
Capital Expenditures-345K-989K-1.04M-181K-210K-312K-350K-2.24M-1.12M-703K
CapEx % of Revenue5.41%5.23%4.91%3.66%1.54%1.9%1.56%9.96%3.17%-
Acquisitions0000210K-27.19M0000
Investments----------
Other Investing-12.88M20.41M00-210K27.19M000-48.9M
Cash from Financing72.07M191.99M96.24M-10.13M220.08M41.76M20.37M26.83M78.19M75.48M
Debt Issued (Net)4.92M42.93M72.95M-10.08M-2.84M-2.93M1.25M9.95M-20.4M0
Equity Issued (Net)67.56M149.04M26.76M550K223.15M46.17M7.38M18.36M100.73M74.14M
Dividends Paid0000000000
Share Repurchases000-26K000000
Other Financing-408K14K-3.47M-601K-227K-1.49M11.74M-1.48M-2.15M1.34M
Net Change in Cash
3.1M▲ 0%
120.64M▲ 3787.9%
-40.85M▼ 133.9%
-77.73M▼ 90.3%
15.26M▲ 119.6%
2.33M▼ 84.7%
39.92M▲ 1611.7%
-797K▼ 102.0%
-34.36M▼ 4211.5%
-9.7M▲ 0%
Free Cash Flow
-56.08M▲ 0%
-91.76M▼ 63.6%
-137.09M▼ 49.4%
-67.6M▲ 50.7%
-56.29M▲ 16.7%
-66.62M▼ 18.4%
-70.51M▼ 5.8%
-62.7M▲ 11.1%
-60.24M▲ 3.9%
-80.76M▲ 0%
FCF Margin %-880.03%-485.17%-643.59%-1365.99%-411.61%-406.52%-314.93%-279.03%-170.87%-190.65%
FCF Growth %-45.69%-63.61%-49.4%50.69%16.74%-18.36%-5.84%11.07%3.92%-37.71%
FCF per Share-9.67-11.66-14.53-5.93-2.67-2.16-2.48-1.99-1.44-1.44
FCF Conversion (FCF/Net Income)0.94x0.97x1.18x0.38x0.19x-0.47x1.16x0.77x0.86x0.92x
Interest Paid005.23M00004.51M01.77M
Taxes Paid0000000000

SENS Key Ratios

Senseonics Holdings, Inc. (SENS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)-4945.69%-239.33%-369.1%----363.59%-817.17%-310.68%-131.45%
Return on Invested Capital (ROIC)-500%-12643.6%-----252.73%--322.64%-322.64%
Gross Margin-53.11%-43.07%-91.3%-350.9%-5.93%16.63%13.81%2.37%44.71%52%
Net Margin-927.37%-496.86%-542.46%-3539.46%-2211.88%867.16%-269.73%-349.84%-196.03%-208.13%
Debt / Equity3.37x0.72x----1.33x-0.68x0.68x
Interest Coverage-18.07x-10.35x-6.63x-9.83x-17.09x8.60x-4.44x-8.32x-12.96x-4.38x
FCF Conversion0.94x0.97x1.18x0.38x0.19x-0.47x1.16x0.77x0.86x0.92x
Revenue Growth1819.58%196.77%12.63%-76.77%176.32%19.85%36.62%0.37%56.89%78.87%

SENS SEC Filings & Documents

Senseonics Holdings, Inc. (SENS) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 7, 2026·SEC

Material company update

May 4, 2026·SEC

Material company update

Mar 12, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 2, 2026·SEC

FY 2025

Mar 3, 2025·SEC

FY 2024

Mar 1, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 7, 2026·SEC

FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 6, 2025·SEC

SENS Frequently Asked Questions

Senseonics Holdings, Inc. (SENS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Senseonics Holdings, Inc. (SENS) reported $42.4M in revenue for fiscal year 2025. This represents a 249071% increase from $0.0M in 2013.

Senseonics Holdings, Inc. (SENS) grew revenue by 56.9% over the past year. This is strong growth.

Senseonics Holdings, Inc. (SENS) reported a net loss of $88.2M for fiscal year 2025.

Dividend & Returns

Senseonics Holdings, Inc. (SENS) has a return on equity (ROE) of -310.7%. Negative ROE indicates the company is unprofitable.

Senseonics Holdings, Inc. (SENS) had negative free cash flow of $80.8M in fiscal year 2025, likely due to heavy capital investments.

Explore More SENS

Senseonics Holdings, Inc. (SENS) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.